Related Experiment Video
Updated: May 30, 2026

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
Bisphosphonates and breast cancer prevention
Rowan T Chlebowski1, Nananda Col
1Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, 1124 W. Carson St. Torrance, CA 90502, USA. rchlebowski@gmail.com
Bisphosphonates may help prevent breast cancer recurrence and bone loss. The Austrian Breast and Colorectal Cancer Study Group (ABCSG) 12 study showed zoledronic acid improved disease-free survival in premenopausal patients.
Area of Science:
- Oncology
- Pharmacology
- Bone Metabolism
Background:
- Bisphosphonates are standard for managing bone complications in breast cancer patients.
- Previous adjuvant trials with oral clodronate showed mixed results on cancer recurrence.
- Zoledronic acid is an intravenous bisphosphonate investigated for breast cancer treatment.
Purpose of the Study:
- To evaluate the efficacy of zoledronic acid in improving disease-free survival in premenopausal breast cancer patients receiving endocrine therapy.
- To assess the impact of zoledronic acid on reducing various types of breast cancer recurrence.
- To explore the potential direct and indirect anti-cancer effects of bisphosphonates.
Main Methods:
- The Austrian Breast and Colorectal Cancer Study Group (ABCSG) 12 trial involved premenopausal breast cancer patients.
- Patients received either endocrine therapy alone or with zoledronic acid.
- Disease-free survival and recurrence rates were analyzed over 62 months.
Main Results:
- Adding zoledronic acid to endocrine therapy significantly prolonged disease-free survival (HR=0.68, p=0.008).
- Zoledronic acid reduced local, regional, and distant breast cancer recurrences.
- Supporting evidence comes from other adjuvant, neoadjuvant, and disseminated tumor cell studies.
Conclusions:
- Intravenous zoledronic acid, when added to endocrine therapy, improves disease-free survival and reduces recurrence in premenopausal breast cancer patients.
- Preclinical data suggest mechanisms for direct and indirect anti-cancer effects of bisphosphonates.
- Observational studies suggest a link between bisphosphonates and lower breast cancer incidence, though confounding factors exist.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

